ORTHOPEDIATRICS CORP Net Income Loss

• ORTHOPEDIATRICS CORP showed a decrease of -4.8% in Net Income Loss from 2024 to 2025.
• This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
• XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2016: -$1.81 million | Q2 2016: -$288.0 thousand | Q3 2016: -$846.0 thousand | Q4 2016: -$3.63 million | Q1 2017: -$1.29 million | Q2 2017: -$1.27 million | Q3 2017: -$1.54 million | Q4 2017: -$4.85 million | Q1 2018: -$5.00 million | Q2 2018: -$2.69 million | Q3 2018: -$1.87 million | Q4 2018: -$2.47 million | Q1 2019: -$3.02 million | Q2 2019: -$2.62 million | Q3 2019: -$2.66 million | Q4 2019: -$5.43 million | Q1 2020: -$4.95 million | Q2 2020: -$9.45 million | Q3 2020: -$4.54 million | Q4 2020: -$14.01 million | Q1 2021: -$10.38 million | Q2 2021: -$3.76 million | Q3 2021: -$2.20 million | Q1 2022: -$9.10 million | Q2 2022: -$333.0 thousand | Q3 2022: $18.54 million | Q1 2023: -$6.81 million | Q2 2023: -$2.89 million | Q3 2023: -$4.59 million | Q1 2024: -$7.81 million | Q2 2024: -$6.03 million | Q3 2024: -$7.92 million | Q1 2025: -$10.66 million | Q2 2025: -$7.11 million | Q3 2025: -$11.77 million.
• Over the full 11 years of available data (2015 to 2025), ORTHOPEDIATRICS CORP's Net Income Loss has declined by 402.4%.
• Historical annual values: Fiscal year 2025: -$39.65 million | Fiscal year 2024: -$37.82 million | Fiscal year 2023: -$20.97 million | Fiscal year 2022: $1.26 million | Fiscal year 2021: -$16.26 million | Fiscal year 2020: -$32.94 million | Fiscal year 2019: -$13.73 million | Fiscal year 2018: -$12.03 million | Fiscal year 2017: -$8.93 million | Fiscal year 2016: -$6.57 million | Fiscal year 2015: -$7.89 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026